Get started
Author

Beatriz Barranco-Fragoso

Observed names: B. Barranco-Fragoso, Beatriz Barranco Fragoso, Beatríz Barranco-Fragoso
OpenAlex ID: A5049445159
Management Strategies for Liver Fibrosis
2016 · Alejandra Altamirano-Barrera, Beatriz Barranco-Fragoso, et al. · Annals of Hepatology · 195
PDF
New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
2018 · Nahum Mendez-Sanchez, Vania Cesar Cruz-Ramon, et al. · International Journal of Molecular Sciences · 177
PDF
Portal vein thrombosis: What is new?
2015 · María del Carmen Manzano-Robleda, Beatriz Barranco-Fragoso, et al. · Annals of Hepatology · 80
PDF
Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis
2021 · Nahum Méndez-Sánchez, Jacqueline Córdova-Gallardo, et al. · Frontiers in Immunology · 50
PDF
Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis
2020 · Nahum Méndez-Sánchez, Eira Cerda-Reyes, et al. · F1000Research · 50
The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
2015 · Paloma Almeda-Valdes, Nancy E. Aguilar Olivos, et al. · BioMed Research International · 41
PDF
A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health
2021 · Mariana M. Ramírez-Mejía, Luis E. Díaz-Orozco, et al. · Medical Science Monitor · 32
Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value
2021 · Fátima Higuera-de-la-Tijera, Jacqueline Córdova-Gallardo, et al. · Digestive Diseases and Sciences · 20
New insights into the association between non-alcoholic fatty liver disease and atherosclerosis
2019 · Alejandro Valencia-Rodríguez, Alfonso Vera-Barajas, et al. · Annals of Translational Medicine · 15
PDF
Factors Associated With Advanced Liver Fibrosis in a Population With Type 2 Diabetes: A Multicentric Study in Mexico City
2025 · Froylan D. Martínez-Sánchez, Maria J. Corredor-Nassar, et al. · Journal of Clinical and Experimental Hepatology · 12
PDF
Identification of Hepatic Dendritic Cells in Liver Biopsies Showing Steatosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Associated with Obesity
2022 · Beatriz Barranco-Fragoso, Shreya C. Pal, et al. · Medical Science Monitor · 11
Epidemiology and etiologic trends of hepatocellular carcinoma in cirrhotic patients in Mexico: a multicenter retrospective study (2018–2024)
2025 · Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía, et al. · Annals of Hepatology · 5
NAFLD-MASLD-MAFLD continuum: A swinging pendulum?
2024 · Mariana M. Ramírez-Mejía, Xingshun Qi, et al. · Annals of Hepatology · 5
Changing Landscape of Liver Cirrhosis Etiologies
2025 · Nahum Méndez-Sánchez, Mariana M Ramírez-Mejía, et al. · Archives of Medical Research · 4
The role of dendritic cells in different stages of non-alcoholic fatty liver disease
2018 · O.L. Ramírez-Pérez, B. Barranco-Fragoso, et al. · Journal of Hepatology · 4
The role of small heterodimer partner in hepatic lipid homeostasis
2015 · Beatriz Barranco-Fragoso, Paloma Almeda-Valdes, et al. · Annals of Hepatology · 4
PDF
The Role of TIPS in Patients with Refractory Ascites and Portal Vein Thrombosis
2017 · Paulina Chinchilla-López, Nashla Hamdan-Pérez, et al. · Annals of Hepatology · 3
PDF
Supervivencia y factores pronósticos en cáncer esofágico
2010 · Alejandro Cruz-Zárate, Angélica Hernández-Guerrero, et al. · Revista Médica Del Hospital General De México · 2
The increasing burden of primary biliary cholangitis-related cirrhosis in Mexico: Evidence from a contemporary multicenter cohort
2026 · N. Méndez-Sánchez, M.M. Ramírez-Mejía, et al. · Revista de Gastroenterología de México (English Edition)
PDF
Su2106 DIAGNOSTIC CONCORDANCE BETWEEN WIDELY USED VCTE CUTOFF POINTS FOR LIVER STEATOSIS AND SIGNIFICANT FIBROSIS IN AN OPEN POPULATION-BASED MASLD COHORT
2026 · Carlos F. Martínez-Cabrera, Graciela Torres-Mendoza, et al. · Gastrointestinal Endoscopy
Su2121 THE RISING BURDEN OF MASLD: YEAR-TO-YEAR PREVALENCE OF LIVER STEATOSIS AND SIGNIFICANT FIBROSIS IN AN OPEN POPULATION COHORT FROM MEXICO CITY (2022-2025)
2026 · Carlos F. Martínez-Cabrera, Graciela Torres-Mendoza, et al. · Gastrointestinal Endoscopy
Su2106 DIAGNOSTIC CONCORDANCE BETWEEN WIDELY USED VCTE CUTOFF POINTS FOR LIVER STEATOSIS AND SIGNIFICANT FIBROSIS IN AN OPEN POPULATION-BASED MASLD COHORT
2026 · Carlos F. Martínez-Cabrera, Graciela Torres-Mendoza, et al. · Gastroenterology
Su2121 THE RISING BURDEN OF MASLD: YEAR-TO-YEAR PREVALENCE OF LIVER STEATOSIS AND SIGNIFICANT FIBROSIS IN AN OPEN POPULATION COHORT FROM MEXICO CITY (2022-2025)
2026 · Carlos F. Martínez-Cabrera, Graciela Torres-Mendoza, et al. · Gastroenterology
THU-030 Impact of alternative VCTE diagnostic criteria on yearly prevalence estimates of MASLD and significant fibrosis
2026 · Carlos Martínez-Cabrera, Marcela Castillo-Medina, et al. · Journal of Hepatology
Carga creciente de la cirrosis por colangitis biliar primaria en México: evidencia de una cohorte multicéntrica contemporánea
2026 · N. Méndez-Sánchez, M.M. Ramírez-Mejía, et al. · Revista de Gastroenterología de México
Works count: 32
Citation count: 710
H-index: 11
I10-index: 11
Year
Topic
Type